Brokerage Dawson James and HC Wainwright both rate this stock as a buy with a target price of $24.00 per share.
garyleemenard
Posts
-
-
Brokerage Dawson James and HC Wainwright both rate this stock as a buy with a target price of $24.00 per share price.
-
Brokerage Dawson James and HC Wainwright both rate this stock as a buy with a target price of $24.00 per share price.
-
Moderna under fire from scientists. Vaccine problems again. Go figure
-
News states: Vaccine will not be ready until late 2021 to 2022.
Based on this news Preventive option is better
-
Disagree stock will be at 10 soon if not higher
-
This company is the holy Grail of preventive medicine.
-
They found the most advanced findings in history for a virus. Additionally market would be the flu season as well. This stock will hit amazing levels when the first around of data is released.
-
This company may be a major winner
-
Friday will be an up day️
-
Outstanding news
-
Great buy today 5.01
-
Heading down
-
Data drives stocks not speculation
-
A lot of speculation
-
Money in the bank
-
Just sold and thank you
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE
SRNE